哈佛生物科学公司:部分业务将同步迁至德国、瑞典及英国设施

美股速递
Jan 30

哈佛生物科学公司宣布,其部分业务运营将进行战略性调整,计划迁移至位于德国、瑞典和英国的生产及研发设施。这一举措旨在优化全球资源配置,提升区域协同效率,强化在欧洲市场的服务能力。公司表示,此次业务转移将遵循分阶段实施原则,确保运营平稳过渡,同时持续为客户提供高质量的产品与技术支援。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10